CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +55,924 | 55,924 | ||
| 2026-10-01 | Spiegel Robert J. Director | Grant or award · Stock Options (right to buy) | +55,924 | 55,924 | ||
| 2026-10-01 | RYAN UNA S Director | Grant or award · Stock Options (right to buy) | +55,924 | 55,924 | ||
| 2026-10-01 | Marton Laurence Director | Grant or award · Stock Options (right to buy) | +55,924 | 55,924 | ||
| 2026-09-10 | VOLL MARK Chief Financial Officer | Grant or award | +80,000 | 222,380 | ||
| 2026-05-19 | VOLL MARK Chief Financial Officer | Purchase | +25,000 | $0.79 | $20K | 142,380 |
| 2026-04-03 | Bagai Shaun Chief Executive Officer | Grant or award · Stock Option | +946,107 | 946,107 | ||
| 2026-04-03 | VOLL MARK Chief Financial Officer | Grant or award | +80,000 | 117,380 | ||
| 2026-04-03 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +128,550 | 128,550 | ||
| 2026-04-03 | Agah Ramtin Chief Medical Officer | Grant or award · Stock Option | +621,727 | 621,727 | ||
| 2026-03-25 | VOLL MARK Chief Financial Officer | Grant or award | +12,380 | 37,380 | ||
| 2026-03-20 | Marton Laurence Director | Purchase | +9,720 | 9,720 | ||
| 2026-03-20 | Marton Laurence Director | Purchase · Warrants | +4,860 | 4,860 | ||
| 2026-03-20 | Bagai Shaun Chief Executive Officer | Purchase | +24,300 | 313,357 | ||
| 2026-03-20 | Bagai Shaun Chief Executive Officer | Purchase · Warrants | +12,150 | 12,150 | ||
| 2026-03-20 | VOLL MARK Chief Financial Officer | Purchase | +97,200 | 97,200 | ||
| 2026-03-20 | VOLL MARK Chief Financial Officer | Purchase · Warrants | +48,600 | 48,600 | ||
| 2026-01-21 | Agah Ramtin Chief Medical Officer | Purchase | +10,000 | $1.00 | $10K | 798,460 |
| 2025-12-31 | Agah Ramtin Chief Medical Officer | Purchase | +9,795 | $0.86 | $8K | 788,460 |
| 2025-12-30 | Agah Ramtin Chief Medical Officer | Purchase | +205 | $0.83 | $169 | 778,665 |
Page 1 of 6 · 120 trades